Keywords: Bristol-Myers Squibb, Third quarter 2009 results
Bristol-Myers sees 64% leap in 3rd quarter 2009 ongoing earnings
Article | 23 October 2009
Slightly beating analysts’ consensus estimates, and helped by cost controls, US drug major Bristol-Myers Squibb posted a 64% increase in third-quarter 2009 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
